Cargando…
Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance
Breast cancer is one of the most common malignancies among women which is often treated with hormone therapy and chemotherapy. Despite the improvements in detection and treatment of breast cancer, the vast majority of breast cancer patients are diagnosed with metastatic disease either at the beginni...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033359/ https://www.ncbi.nlm.nih.gov/pubmed/29983888 http://dx.doi.org/10.18632/oncotarget.25596 |